Kinase suppressor of ras (ksr1) modulates multiple kit-ligand-dependent mast cell functions

Experimental Hematology

Volumn 39, Issue 10, 2011, Pages 969-976

  Chen, Mia ^a   Burgin, Sarah ^a   Staser, Karl ^a   He, Yongzheng ^a   Li, Xiaohong ^a   Robinson, Mikella ^a   Jiang, Li ^a   Chan, Rebecca J ^a   Ingram, David ^a   Clapp, D Wade ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

F ACTIN; KINASE SUPPRESSOR OF RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; P21 ACTIVATED KINASE; RAF PROTEIN; SCAFFOLD PROTEIN; STEM CELL FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; GENE; GENE DISRUPTION; KINASE SUPPRESSOR OF RAS GENE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN POLYMERIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; CELL CYCLE; CELL DEGRANULATION; CELL DIVISION; CELLS, CULTURED; CYTOSKELETON; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; MAST CELLS; MICE; MICE, KNOCKOUT; P21-ACTIVATED KINASES; PROTEIN KINASES; RAF KINASES; STEM CELL FACTOR;

MUS;

EID: 80052861295     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2011.06.009     Document Type: Article

References (30)

1. Galli S.J., Grimbaldeston M., Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008, 8:478-486.
2. Piliponsky A.M., Chen C.C., Nishimura T., et al. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis. Nat Med 2008, 14:392-398.
3. Metz M., Piliponsky A.M., Chen C.C., et al. Mast cells can enhance resistance to snake and honeybee venoms. Science 2006, 313:526-530.
4. Maurer M., Wedemeyer J., Metz M., et al. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004, 432:512-516.
5. Yu M., Tsai M., Tam S.Y., Jones C., Zehnder J., Galli S.J. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 2006, 116:1633-1641.
6. Coussens L.M., Werb Z. Inflammatory cells and cancer: think different!. J Exp Med 2001, 193:F23-F26.
7. Yang F.C., Ingram D.A., Chen S., et al. Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow. Cell 2008, 135:437-448.
8. Tsai M., Takeishi T., Thompson H., et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci U S A 1991, 88:6382-6386.
9. Taylor A.M., Galli S.J., Coleman J.W. Stem-cell factor, the kit ligand, induces direct degranulation of rat peritoneal mast cells in vitro and in vivo: dependence of the in vitro effect on period of culture and comparisons of stem-cell factor with other mast cell-activating agents. Immunology 1995, 86:427-433.
10. Galli S.J., Tsai M., Wershil B.K. The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 1993, 142:965-974.
11. Ingram D.A., Hiatt K., King A.J., et al. Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro. J Exp Med 2001, 194:57-69.
12. Yang F.C., Ingram D.A., Chen S., et al. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells. J Clin Invest 2003, 112:1851-1861.
13. Kalesnikoff J., Rios E.J., Chen C.C., et al. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells. Proc Natl Acad Sci U S A 2006, 103:2659-2664.
14. Yang F.C., Kapur R., King A.J., et al. Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells. Immunity 2000, 12:557-568.
15. McDaniel A.S., Allen J.D., Park S.J., et al. Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells. Blood 2008, 112:4646-4654.
16. Khalaf W.F., Yang F.C., Chen S., et al. K-ras is critical for modulating multiple c-kit-mediated cellular functions in wild-type and Nf1+/- mast cells. J Immunol 2007, 178:2527-2534.
17. Therrien M., Michaud N.R., Rubin G.M., Morrison D.K. KSR modulates signal propagation within the MAPK cascade. Genes Dev 1996, 10:2684-2695.
18. McKay M.M., Ritt D.A., Morrison D.K. Signaling dynamics of the KSR1 scaffold complex. Proc Natl Acad Sci U S A 2009, 106:11022-11027.
19. Kortum R.L., Lewis R.E. The molecular scaffold KSR1 regulates the proliferative and oncogenic potential of cells. Mol Cell Biol 2004, 24:4407-4416.
20. Razidlo G.L., Kortum R.L., Haferbier J.L., Lewis R.E. Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation. J Biol Chem 2004, 279:47808-47814.
21. Kim M., Yan Y., Kortum R.L., et al. Expression of kinase suppressor of Ras1 enhances cisplatin-induced extracellular signal-regulated kinase activation and cisplatin sensitivity. Cancer Res 2005, 65:3986-3992.
22. Szatmari E., Kalita K.B., Kharebava G., Hetman M. Role of kinase suppressor of Ras-1 in neuronal survival signaling by extracellular signal-regulated kinase 1/2. J Neurosci 2007, 27:11389-11400.
23. Janssen R.A., Kim P.N., Mier J.W., Morrison D.K. Overexpression of kinase suppressor of Ras upregulates the high-molecular-weight tropomyosin isoforms in ras-transformed NIH 3T3 fibroblasts. Mol Cell Biol 2003, 23:1786-1797.
24. Nguyen A., Burack W.R., Stock J.L., et al. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol Cell Biol 2002, 22:3035-3045.
25. Ingram D.A., Yang F.C., Travers J.B., et al. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo. J Exp Med 2000, 191:181-188.
26. Ingram D.A., Zhang L., McCarthy J., et al. Lymphoproliferative defects in mice lacking the expression of neurofibromin: functional and biochemical consequences of Nf1 deficiency in T-cell development and function. Blood 2002, 100:3656-3662.
27. Chen S., Burgin S., McDaniel A., et al. Nf1-/- Schwann cell-conditioned medium modulates mast cell degranulation by c-Kit-mediated hyperactivation of phosphatidylinositol 3-kinase. Am J Pathol 2010, 177:3125-3132.
28. Meloche S., Pouyssegur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene 2007, 26:3227-3239.
29. Coussens L.M., Raymond W., Bergers G., et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 1999, 13:1382-1397.
30. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.